Genmab A (GMAB) Other Non Operating Income (2024 - 2026)
Genmab A (GMAB) reported Other Non Operating Income of -$163.0 million for Q1 2026, down 1353.85% on a YoY basis from $13.0 million in Q1 2025, and down 2816.67% quarter-over-quarter from $6.0 million in Q3 2025.
Genmab A (GMAB) Other Non Operating Income (2024 - 2026) Analysis & Trends
Genmab A has reported Other Non Operating Income for 3 years, with the latest figure at -$163.0 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Genmab A | 48.57 Bn | 47.05 Bn | 831.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -163.00 Mn |
| Sep 30, 2025 | 6.00 Mn |
| Jun 30, 2025 | 3.00 Mn |
| Mar 31, 2025 | 13.00 Mn |
| Sep 30, 2024 | 129.00 Mn |
| Jun 30, 2024 | -30.00 Mn |
| Mar 31, 2024 | 7.00 Mn |